MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Alpine Immune Sciences, Inc. - Common Stock (NQ:ALPN)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, May 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Alpine Immune Sciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Wall Street Braces For Another Red Day Ahead Of More Inflation Data While Bitcoin Holds Above $70K: Analyst Sees Any Pullback As 'Phenomenal Buying Opportunity' ↗
The negative mood on Wall Street may persist as investors await the release of another inflation report, which will have significant implications for the near-term trend in cons 
Via Benzinga
Topics Economy
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗
We're starting off Thursday with a breakdown of all the biggest pre-market stock movers traders will want to keep an eye on this morning! 
Via InvestorPlace
News headline image
Why Rallybio Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket ↗
Shares of Rallybio Corporation (NASDAQ: RLYB) rose sharply in today’s pre-market trading after the company announced a collaboration with Johnson & Johnson to advance therapeutics for pregnant... 
Via Benzinga
News headline image
Navigating 8 Analyst Ratings For Alpine Immune Sciences ↗
 
Via Benzinga
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 3/19
Via Investor Brand Network
News headline image
Evaluating Alpine Immune Sciences: Insights From 6 Financial Analysts ↗
 
Via Benzinga
News headline image
Why Bitcoin-Linked MicroStrategy Along With Adial Pharmaceuticals, Alpine Immune Sciences, Marin Software, And Tesla Are On Investors' Radars Today ↗
On Wednesday, key U.S. stock indexes closed lower, as the Dow Jones Industrial Average fell by 1.1% to 38,461.51, the S&P 500 dropped nearly 1% to 5,160.64, and the Nasdaq ended the day down by 0.8% at... 
Via Benzinga
Topics Stocks
News headline image
ALPN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Alpine Immune Sciences, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Vertex Pharmaceuticals Nabs Alpine Immune Sciences In $4.9 Billion Deal ↗
The companies expect the deal to close later this quarter. 
Via Investor's Business Daily
News headline image
Alpine Immune Sciences Shares Updated Clinical Data from Povetacicept in IgA Nephropathy
From Alpine Immune Sciences, Inc.
Via Business Wire
News headline image
Recap: Alpine Immune Sciences Q4 Earnings ↗
 
Via Benzinga
News headline image
Preview: Alpine Immune Sciences's Earnings ↗
 
Via Benzinga
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 3/8
Via Investor Brand Network
News headline image
Vertex Enters Into Agreement to Acquire Alpine Immune Sciences
From Alpine Immune Sciences, Inc.
Via Business Wire
News headline image
Why Is Kidney Disease-Focused Alpine Immune Sciences Stock Trading Higher On Wednesday? ↗
Alpine Immune Sciences explores strategic options, potentially selling amid interest from buyers. The Seattle-based firm, with soaring stock up over 400%, evaluates various possibilities. 
Via Benzinga
News headline image
Lamb Weston Reports Weak Earnings, Joins Paragon 28, Resources Connection And Other Big Stocks Moving Lower On Thursday ↗
U.S. stocks were higher, with the Dow Jones gaining over 150 points on Thursday. 
Via Benzinga
Topics Stocks
Alpine Immune Sciences Inc. (NASDAQ: ALPN) is a Stock Spotlight on 2/29
Via Investor Brand Network
News headline image
In-Depth Examination Of 6 Analyst Recommendations For Alpine Immune Sciences ↗
 
Via Benzinga
News headline image
Alpine Immune Sciences to Present Updated Clinical Data for Povetacicept in IgA Nephropathy at the World Congress of Nephrology 2024
From Alpine Immune Sciences, Inc.
Via Business Wire
News headline image
Alpine Immune Sciences Presents New Translational Data on Povetacicept at the European Lupus Meeting 2024
From Alpine Immune Sciences, Inc.
Via Business Wire
News headline image
Alpine Immune Sciences to Participate in Upcoming H.C. Wainwright 2nd Annual Autoimmune & Inflammatory Disease Virtual Conference
From Alpine Immune Sciences, Inc.
Via Business Wire
News headline image
Why Peraso Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. 
Via Benzinga
News headline image
Alpine Immune Sciences Analysts Boost Their Forecasts After Q4 Earnings ↗
Alpine Immune Sciences, Inc. (NASDAQ: ALPN) reported better-than-expected fourth-quarter financial results. 
Via Benzinga
News headline image
National CineMedia Reports Upbeat Results, Joins Nordstrom, Core & Main And Other Big Stocks Moving Higher On Tuesday ↗
U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday. 
Via Benzinga
Topics Stocks
News headline image
ALPN Stock Earnings: Alpine Immune Sciences Beats EPS, Beats Revenue for Q4 2023 ↗
ALPN stock results show that Alpine Immune Sciences beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Alpine Immune Sciences Provides Corporate Update and Full Year 2023 Financial Results
From Alpine Immune Sciences, Inc.
Via Business Wire
News headline image
Earnings Scheduled For March 18, 2024 ↗
Companies Reporting Before The Bell • Niu Techs (NASDAQ:NIU) is expected to report earnings for its fourth quarter. 
Via Benzinga
News headline image
Alpine Immune Sciences to Report Fourth Quarter and Full Year 2023 Financial Results
From Alpine Immune Sciences, Inc.
Via Business Wire
News headline image
Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
From Alpine Immune Sciences, Inc.
Via Business Wire
News headline image
Alpine Immune Sciences to Participate in Two Upcoming Healthcare Conferences
From Alpine Immune Sciences, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story